Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A pill for men? new trial tests potential Game-Changer in contraception

NCT ID NCT06542237

Summary

This study is testing a new daily oral medication, YCT-529, as a potential form of birth control for men. It aims to find a safe and effective dose by giving the pill to healthy male volunteers for 28, 90, or 180 days. Researchers will closely monitor participants for side effects and check how the drug affects hormone levels and sperm production.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALE CONTRACEPTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • New Zealand Clinical Research (NZCR)

    RECRUITING

    Grafton, Auckland, 1010, New Zealand

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.